BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36509010)

  • 1. A preliminary analysis of prognostic genes in advanced laryngeal squamous cell carcinoma patients with postoperative radiotherapy.
    Hu C; Lao Z; Yan L; Song X; Wang J
    Pathol Res Pract; 2023 Jan; 241():154229. PubMed ID: 36509010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry.
    Li JD; Chen Y; Jing SW; Wang LT; Zhou YH; Liu ZS; Song C; Li DZ; Wang HQ; Huang ZG; Dang YW; Chen G; Luo JY
    Eur J Med Res; 2023 Dec; 28(1):591. PubMed ID: 38102653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.
    Tang XZ; Zhou XG; Zhang XG; Li GS; Chen G; Dang YW; Huang ZG; Li MX; Liang Y; Yao YX; Chen XY; Rong MH; Huang SN
    Cancer Biomark; 2020; 29(1):111-124. PubMed ID: 32623386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.
    Mo BY; Li GS; Huang SN; Wei ZX; Su YS; Dai WB; Ruan L
    Med Sci Monit; 2020 Dec; 26():e928185. PubMed ID: 33361747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma.
    Zhong F; Lu HP; Chen G; Dang YW; Li GS; Chen XY; Qin YY; Yao YX; Zhang XG; Liang Y; Li MX; Mo M; Zhang KL; Ding H; Huang ZG; Wei ZX
    Pathol Res Pract; 2020 Feb; 216(2):152785. PubMed ID: 31889588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key modules and hub genes identified by coexpression network analysis for revealing novel biomarkers for larynx squamous cell carcinoma.
    Zhang H; Zhao X; Wang M; Ji W
    J Cell Biochem; 2019 Dec; 120(12):19832-19840. PubMed ID: 31310372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.
    Wu JY; Lan XL; Yan DM; Fang YY; Peng YX; Liang FF; Jiang L; Huang SN; Mo M; Lin CX; Niu YT; Wu XW; Wei ZX
    Pathol Res Pract; 2022 Feb; 230():153751. PubMed ID: 34999279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
    Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR
    Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of zinc finger protein 71 in laryngeal squamous cell carcinoma tissues and its potential molecular mechanism and clinical significance: a study based on immunohistochemistry staining and data mining.
    Jiang FC; Luo JY; Dang YW; Lu HP; Li DM; Huang ZG; Tang YL; Fang YY; Tang YX; Su YS; Dai WB; Pan SL; Feng ZB; Chen G; He J
    World J Surg Oncol; 2022 Nov; 20(1):359. PubMed ID: 36369089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
    Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
    Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel molecules and pathways associated with fascin actin‑bundling protein 1 in laryngeal squamous cell carcinoma through comprehensive transcriptome analysis.
    Liu H; Hao W; Wang X; Zhang Y; He L; Xue X; Yang J; Zhang C
    Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
    Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
    Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Cycle-Related Gene SPC24: A Novel Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Cancer.
    Chen J; Luo J; He J; Jiang X; Jiang N; Yang C; Zhong S
    Biomed Res Int; 2023; 2023():1733100. PubMed ID: 36718148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer.
    Zhang H; Chen Z; Huang Q; Guo Y; Wang M; Wu C
    Cell Oncol (Dordr); 2023 Aug; 46(4):1015-1030. PubMed ID: 36964893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
    de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
    Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.